Stocks
Arcturus Therapeutics Holdings (ARCT) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -201.7 | 13.7 | -24.2 | -77.4 | -71.9 | -72.8 | ||
| Changes by years, y/y, % | +185% | -107% | -276% | +220% | -7% | +0.4% | |||
Arcturus Therapeutics Holdings. EBITDA US GAAP, bln rub
Arcturus Therapeutics Holdings. EBITDA US GAAP, changes, %
Arcturus Therapeutics Holdings. EBITDA US GAAP, sum by quarters, bln rub
Arcturus Therapeutics Holdings (ARCT) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -16.0 | -10.8 | -12.7 | -20.1 | -29.1 | -72.8 | |
| Changes by years, y/y, % | -46% | -46% | +104% | -31% | +82% | |||
| Changes by quarters, q/q, % | -45% | -32% | +17% | +59% | +45% | |||
